Predicting drug-drug interactions in drug discovery: where are we now and where are we going?
about
A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo.Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.INDI: a computational framework for inferring drug interactions and their associated recommendations.
P2860
Predicting drug-drug interactions in drug discovery: where are we now and where are we going?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Predicting drug-drug interacti ...... we now and where are we going?
@ast
Predicting drug-drug interacti ...... we now and where are we going?
@en
type
label
Predicting drug-drug interacti ...... we now and where are we going?
@ast
Predicting drug-drug interacti ...... we now and where are we going?
@en
prefLabel
Predicting drug-drug interacti ...... we now and where are we going?
@ast
Predicting drug-drug interacti ...... we now and where are we going?
@en
P2093
P1476
Predicting drug-drug interacti ...... we now and where are we going?
@en
P2093
Dean M Messing
Larry C Wienkers
Matthew Hutzler
P577
2005-01-01T00:00:00Z